Literature DB >> 22334165

Amyotrophic lateral sclerosis and palliative care: where we are, and the road ahead.

Leslie J Blackhall1.   

Abstract

Patients with amyotrophic lateral sclerosis (ALS) have high symptom burdens, including pain, fatigue, dyspnea, and sialorrhea, and they must make difficult decisions about the use of life-prolonging therapies, such as long-term mechanical ventilation. The impact of ALS is also felt by family caregivers who often struggle to meet the heavy physical, financial, and emotional demands associated with the illness. Expert multidisciplinary care may improve both quality and length of life of patients with ALS. However, although advances have been made in the treatment of some symptoms, others, including pain management, remain poorly studied. Involvement of palliative care specialists as part of the ALS multidisciplinary team is recommended, as we continue to work toward improving the quality of life for patients and their families.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22334165     DOI: 10.1002/mus.22305

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  17 in total

Review 1.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

Review 2.  Neuropalliative care: Priorities to move the field forward.

Authors:  Claire J Creutzfeldt; Benzi Kluger; Adam G Kelly; Monica Lemmon; David Y Hwang; Nicholas B Galifianakis; Alan Carver; Maya Katz; J Randall Curtis; Robert G Holloway
Journal:  Neurology       Date:  2018-06-27       Impact factor: 9.910

Review 3.  Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era.

Authors:  Ximena Paez-Colasante; Claudia Figueroa-Romero; Stacey A Sakowski; Stephen A Goutman; Eva L Feldman
Journal:  Nat Rev Neurol       Date:  2015-04-21       Impact factor: 42.937

Review 4.  Neuro-oncology and palliative care: a challenging interface.

Authors:  Esther Lin; Mark A Rosenthal; Brian H Le; Peter Eastman
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

Review 5.  Symptom Management and End-of-Life Care in Amyotrophic Lateral Sclerosis.

Authors:  Carlayne E Jackson; April L McVey; Stacy Rudnicki; Mazen M Dimachkie; Richard J Barohn
Journal:  Neurol Clin       Date:  2015-11       Impact factor: 3.806

Review 6.  Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway-PPAR Gamma, Energy Metabolism and Circadian Rhythms.

Authors:  Alexandre Vallée; Yves Lecarpentier; Rémy Guillevin; Jean-Noël Vallée
Journal:  Neuromolecular Med       Date:  2018-03-23       Impact factor: 3.843

7.  The Prevalence and Management of Saliva Problems in Motor Neuron Disease: A 4-Year Analysis of the Scottish Motor Neuron Disease Register.

Authors:  Iona Pearson; Stella A Glasmacher; Judith Newton; Emily Beswick; Arpan R Mehta; Richard Davenport; Siddharthan Chandran; Suvankar Pal
Journal:  Neurodegener Dis       Date:  2021-04-26       Impact factor: 2.977

8.  Localization of Salivary Glands for Botulinum Toxin Treatment: Ultrasound Versus Landmark Guidance.

Authors:  Sebastian Loens; Norbert Brüggemann; Armin Steffen; Tobias Bäumer
Journal:  Mov Disord Clin Pract       Date:  2019-12-30

Review 9.  Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis.

Authors:  Sabrina Paganoni; Chafic Karam; Nanette Joyce; Richard Bedlack; Gregory T Carter
Journal:  NeuroRehabilitation       Date:  2015       Impact factor: 2.138

Review 10.  Rehabilitation in amyotrophic lateral sclerosis: why it matters.

Authors:  Salony Majmudar; Jason Wu; Sabrina Paganoni
Journal:  Muscle Nerve       Date:  2014-05-17       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.